Brain (and spinal cord) tumours, Children's cancers
Results
Phase 1
This trial looked at erlotinib (also called Tarceva and OSI - 774) for children and young adults with brain tumours.
Recruitment start: 1 June 2005
Recruitment end: 30 August 2007
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Darren Hargrave
Children's Cancer and Leukaemia Group (CCLG)
National Institute for Health Research Cancer Research Network (NCRN)
Last reviewed: 21 March 2012
CRUK internal database number: 692
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
